NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan
· Delayed Price · Currency is TWD 19.50
-0.50 (-2.50%)
At close: Mar 9, 2026
TPEX:4732 Revenue
NatureWise Biotech & Medicals had revenue of 86.77M TWD in the half year ending June 30, 2025, with 30.75% growth. This brings the company's revenue in the last twelve months to 180.29M, down -19.72% year-over-year. In the year 2024, NatureWise Biotech & Medicals had annual revenue of 224.32M with 40.08% growth.
Revenue (ttm)
180.29M
Revenue Growth
-19.72%
P/S Ratio
5.08
Revenue / Employee
5.63M
Employees
31
Market Cap
916.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 224.32M | 64.18M | 40.08% |
| Dec 31, 2023 | 160.14M | -68.45M | -29.94% |
| Dec 31, 2022 | 228.59M | -21.21M | -8.49% |
| Dec 31, 2021 | 249.80M | -57.12M | -18.61% |
| Dec 31, 2020 | 306.92M | -546.00K | -0.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TCI GENE | 324.73M |
| Taiwan Advance Bio-Pharmaceutical | 371.86M |
| Neith | 39.35M |
| Eusol Biotech | 370.00K |
| Level Biotechnology | 736.59M |
| Holy Stone Healthcare | 47.51M |
| Lukas Biomedical | 180.32M |
| BioLASCO Taiwan | 277.12M |